Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
The Open Virology Journal
|
September 14, 2010
HSV Recombinant Vectors for Gene Therapy
Roberto Manservigi, Rafaela Argnani, Peggy Marconi
Current Gene Therapy
|
October 28, 2005
HSV-1-derived recombinant and amplicon vectors for gene transfer and gene therapy
Alberto L Epstein, Peggy Marconi, Rafaela Argnani, et al.
Gene Therapy
|
April 2, 2004
Specific targeted binding of herpes simplex virus type 1 to hepatocytes via the human hepatitis B virus preS1 peptide
Rafaela Argnani, Luca Boccafogli, Peggy C Marconi, et al.
Advances in Experimental Medicine and Biology
|
January 5, 2010
HSV as a vector in vaccine development and gene therapy
Peggy Marconi, Rafaela Argnani, Alberto L Epstein, et al.
Human Vaccines
|
May 24, 2008
HSV as a vector in vaccine development and gene therapy
Peggy Marconi, Rafaela Argnani, Elena Berto, et al.
International Journal of Pharmaceutics
|
June 30, 2012
Intranasal immunization in mice with non-ionic surfactants vesicles containing HSV immunogens: a preliminary study as possible vaccine against genital herpes
Rita Cortesi, Laura Ravani, Francesca Rinaldi, et al.
Viruses
|
September 7, 2019
Role of Herpes Simplex Envelope Glycoprotein B and Toll-Like Receptor 2 in Ocular Inflammation: An ex vivo Organotypic Rabbit Corneal Model
Andreana Marino, Simona Pergolizzi, Francesco Cimino, et al.
Plos One
|
November 19, 2010
APP processing induced by herpes simplex virus type 1 (HSV-1) yields several APP fragments in human and rat neuronal cells
Giovanna De Chiara, Maria Elena Marcocci, Livia Civitelli, et al.
Antimicrobial Agents and Chemotherapy
|
June 25, 2008
Inhibition of herpes simplex virus types 1 and 2 in vitro infection by sulfated derivatives of Escherichia coli K5 polysaccharide
Debora Pinna, Pasqua Oreste, Tiziana Coradin, et al.
Vaccine
|
December 18, 2004
Immunotherapeutic activity of a recombinant combined gB-gD-gE vaccine against recurrent HSV-2 infections in a guinea pig model
Roberto Manservigi, Anna Boero, Rafaela Argnani, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
The Open Virology Journal
|
September 14, 2010
HSV Recombinant Vectors for Gene Therapy
Roberto Manservigi, Rafaela Argnani, Peggy Marconi
Current Gene Therapy
|
October 28, 2005
HSV-1-derived recombinant and amplicon vectors for gene transfer and gene therapy
Alberto L Epstein, Peggy Marconi, Rafaela Argnani, et al.
Gene Therapy
|
April 2, 2004
Specific targeted binding of herpes simplex virus type 1 to hepatocytes via the human hepatitis B virus preS1 peptide
Rafaela Argnani, Luca Boccafogli, Peggy C Marconi, et al.
Advances in Experimental Medicine and Biology
|
January 5, 2010
HSV as a vector in vaccine development and gene therapy
Peggy Marconi, Rafaela Argnani, Alberto L Epstein, et al.
Human Vaccines
|
May 24, 2008
HSV as a vector in vaccine development and gene therapy
Peggy Marconi, Rafaela Argnani, Elena Berto, et al.
International Journal of Pharmaceutics
|
June 30, 2012
Intranasal immunization in mice with non-ionic surfactants vesicles containing HSV immunogens: a preliminary study as possible vaccine against genital herpes
Rita Cortesi, Laura Ravani, Francesca Rinaldi, et al.
Viruses
|
September 7, 2019
Role of Herpes Simplex Envelope Glycoprotein B and Toll-Like Receptor 2 in Ocular Inflammation: An ex vivo Organotypic Rabbit Corneal Model
Andreana Marino, Simona Pergolizzi, Francesco Cimino, et al.
Plos One
|
November 19, 2010
APP processing induced by herpes simplex virus type 1 (HSV-1) yields several APP fragments in human and rat neuronal cells
Giovanna De Chiara, Maria Elena Marcocci, Livia Civitelli, et al.
Antimicrobial Agents and Chemotherapy
|
June 25, 2008
Inhibition of herpes simplex virus types 1 and 2 in vitro infection by sulfated derivatives of Escherichia coli K5 polysaccharide
Debora Pinna, Pasqua Oreste, Tiziana Coradin, et al.
Vaccine
|
December 18, 2004
Immunotherapeutic activity of a recombinant combined gB-gD-gE vaccine against recurrent HSV-2 infections in a guinea pig model
Roberto Manservigi, Anna Boero, Rafaela Argnani, et al.
Page
of 2